SignatureFD’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.23K Hold
294
﹤0.01% 2711
2026
Q1
$8.39K Sell
294
-51
-15% -$1.74K ﹤0.01% 2579
2025
Q4
$13.6K Buy
345
+27
+8% +$990 ﹤0.01% 2288
2025
Q3
$11.2K Hold
318
﹤0.01% 2371
2025
Q2
$10.4K Hold
318
﹤0.01% 2332
2025
Q1
$10.3K Sell
318
-34
-10% -$1.26K ﹤0.01% 2342
2024
Q4
$10.8K Hold
352
﹤0.01% 2334
2024
Q3
$9.87K Sell
352
-121
-26% -$2.98K ﹤0.01% 2340
2024
Q2
$10.8K Buy
473
+467
+7,783% +$10.8K ﹤0.01% 2232
2024
Q1
$183 Sell
6
-140
-96% -$4.69K ﹤0.01% 3103
2023
Q4
$5.21K Buy
146
+60
+70% +$2.23K ﹤0.01% 2483
2023
Q3
$3.77K Buy
86
+39
+83% +$1.9K ﹤0.01% 2591
2023
Q2
$2.32K Buy
47
+13
+38% +$599 ﹤0.01% 2763
2023
Q1
$1.41K Sell
34
-17
-33% -$705 ﹤0.01% 2902
2022
Q4
$2.26K Sell
51
-102
-67% -$4.26K ﹤0.01% 2771
2022
Q3
$6K Sell
153
-86
-36% -$3.93K ﹤0.01% 2312
2022
Q2
$10K Buy
239
+183
+327% +$8.67K ﹤0.01% 2095
2022
Q1
$4K Buy
56
+48
+600% +$3.11K ﹤0.01% 2552
2021
Q4
$1K Buy
+8
New +$581 ﹤0.01% 2870
2021
Q3
Sell
-21
Closed -$2K 3033
2021
Q2
$2K Buy
+21
New +$1.53K ﹤0.01% 2538

Other funds holding ATRC

SignatureFD's ATRC Position: Q2 2026 in Review

SignatureFD held its AtriCure (ATRC) position steady in Q2 2026 at 294 shares worth $8.23K. The position accounts for ﹤0.01% of the portfolio, ranked #2711.

SignatureFD first reported a position in ATRC in Q2 2021 and has held it in 20 quarters since. The position peaked at $13.6K in Q4 2025. 251 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • SignatureFD held 294 shares of AtriCure worth $8.23K as of Q2 2026.
  • SignatureFD left its AtriCure share count unchanged in Q2 2026.
  • AtriCure made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #2711 holding.
  • SignatureFD first reported a position in AtriCure in Q2 2021 and has held it in 20 quarters since.
  • SignatureFD's AtriCure position peaked at $13.6K in Q4 2025.
  • 251 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.